Literature DB >> 21965124

Plasmin generation and fibrinolysis in pediatric patients undergoing cardiopulmonary bypass surgery.

Vera Ignjatovic1, Aparajith Chandramouli, Jenny Than, Robyn Summerhayes, Fiona Newall, Steve Horton, Andrew Cochrane, Paul Monagle.   

Abstract

This prospective, single-centre cohort study aimed to evaluate plasmin generation and fibrinolysis during and after cardiopulmonary bypass (CPB) surgery in a cohort of children up to 6 years of age. Blood samples were drawn at eight time points: after induction of anesthesia, before unfractionated heparin (UFH), after UFH, after initiation of bypass, before protamine, after protamine, after chest closure, and 6 h after chest closure. The study identified an increase in fibrinolysis during CPB and particularly up to 6 h afterward in children. This could be the mechanism for the significant bleeding events observed in this young population after CPB. This study establishes the foundation for future studies in this area, particularly those focusing on clinical outcomes after CPB surgery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21965124     DOI: 10.1007/s00246-011-0122-6

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  22 in total

1.  Activation of coagulation and fibrinolysis during cardiothoracic operations.

Authors:  B J Hunt; R N Parratt; H C Segal; S Sheikh; P Kallis; M Yacoub
Journal:  Ann Thorac Surg       Date:  1998-03       Impact factor: 4.330

2.  Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.

Authors:  M Levi; M E Cromheecke; E de Jonge; M H Prins; B J de Mol; E Briët; H R Büller
Journal:  Lancet       Date:  1999-12-04       Impact factor: 79.321

Review 3.  Cardiopulmonary bypass in infants and children: how is it different?

Authors:  L K Davies
Journal:  J Cardiothorac Vasc Anesth       Date:  1999-06       Impact factor: 2.628

4.  Influence of high-dose aprotinin on anticoagulation, heparin requirement, and celite- and kaolin-activated clotting time in heparin-pretreated patients undergoing open-heart surgery. A double-blind, placebo-controlled study.

Authors:  W Dietrich; G Dilthey; M Spannagl; M Jochum; S L Braun; J A Richter
Journal:  Anesthesiology       Date:  1995-10       Impact factor: 7.892

5.  Factors associated with blood loss and blood product transfusions: a multivariate analysis in children after open-heart surgery.

Authors:  G D Williams; S L Bratton; C Ramamoorthy
Journal:  Anesth Analg       Date:  1999-07       Impact factor: 5.108

Review 6.  Development of the hemostatic system in the neonate and young infant.

Authors:  M Andrew; B Paes; M Johnston
Journal:  Am J Pediatr Hematol Oncol       Date:  1990

Review 7.  Thrombin activatable fibrinolysis inhibitor (TAFI)--how does thrombin regulate fibrinolysis?

Authors:  Bonno N Bouma; Laurent O Mosnier
Journal:  Ann Med       Date:  2006       Impact factor: 4.709

Review 8.  Mediastinal bleeding after cardiopulmonary bypass in pediatric patients.

Authors:  J Guay; G E Rivard
Journal:  Ann Thorac Surg       Date:  1996-12       Impact factor: 4.330

9.  Development of the human coagulation system in the full-term infant.

Authors:  M Andrew; B Paes; R Milner; M Johnston; L Mitchell; D M Tollefsen; P Powers
Journal:  Blood       Date:  1987-07       Impact factor: 22.113

Review 10.  Activation of hemostasis during cardiopulmonary bypass and pediatric aprotinin dosage.

Authors:  H Mössinger; W Dietrich
Journal:  Ann Thorac Surg       Date:  1998-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.